3HB.STU Hybrigenics Société Anonyme

Healthcare Biotechnology Stuttgart Exchange
0.0082 EUR
Close of Oct 31, 2026
0.0002 0.0258
Market cap
EUR 9.09M
P/E
-
P/B
245.75x
ROE
-2,600.0%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is 3HB.STU undervalued?

Graham number

The Graham number of Hybrigenics Société Anonyme cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Hybrigenics Société Anonyme fundamental analysis

No fundamental analysis for Hybrigenics Société Anonyme yet.

Hybrigenics Société Anonyme stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Hybrigenics Société Anonyme

Hybrigenics SA, together with its subsidiaries, operates as a biotechnology company in France. The company engages in development of biotechnology in the field of biotechnology, oncology, regenerative medicine, and anti-aging medicine. It is also involved in the development of technical solutions using adipose tissue cells and stem cells. The company is headquartered in Gallargues-le-Montueux, France. Hybrigenics SA is a subsidiary of Diagnostic Medical Systems S.A.

Full company profile